CJC-1295 + Ipamorelin

CJC-1295 + Ipamorelin – Available in 10mg and 20mg vial

Dual-Pathway Research Blend for Growth Hormone Signalling & Endocrine Regulation

CJC-1295 + Ipamorelin combines two widely studied research compounds that interact with distinct pathways involved in growth hormone (GH) release and endocrine signalling. This combination is frequently investigated in laboratory models examining how the body regulates natural growth hormone secretion through multiple complementary mechanisms.

Researchers often study this pairing because each compound acts through a separate biological pathway, making it a valuable tool for exploring growth hormone pulsatility, pituitary function, and integrated endocrine regulation.

Key Features

✓Combines a GHRH analogue with a selective GH secretagogue

✓Studied for dual-pathway growth hormone signalling

✓Frequently researched in endocrine and pituitary models

✓Investigated for natural GH pulsatility patterns

✓Explores interactions between GHRH and ghrelin receptor pathways

✓Popular within growth hormone and IGF-1 signalling research

Why Researchers Study CJC-1295 + Ipamorelin

Dual Growth Hormone Signalling

Combines two compounds that stimulate growth hormone release through separate regulatory mechanisms, allowing researchers to investigate integrated GH pathway activity.

Growth Hormone Pulsatility Research

Frequently studied in models examining natural growth hormone release patterns and pulsatile endocrine signalling.

Pituitary Function Studies

Researchers investigate how the pituitary gland responds to multiple signalling inputs involved in hormone regulation.

Endocrine Pathway Exploration

Provides a framework for examining interactions between growth hormone-releasing hormone (GHRH) pathways and ghrelin receptor activation.

Scientific Research Context

CJC-1295

CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue that is studied for its interaction with hypothalamic and pituitary signalling pathways involved in growth hormone secretion.

Researchers investigate CJC-1295 to better understand:

• Growth hormone release mechanisms
• Pituitary stimulation pathways
• Endocrine feedback systems
• GH and IGF-1 signalling relationships

Ipamorelin

Ipamorelin is a selective growth hormone secretagogue that activates the growth hormone secretagogue receptor (GHS-R), commonly known as the ghrelin receptor.

Research involving Ipamorelin often focuses on:

• Ghrelin receptor signalling
• Growth hormone regulation
• Endocrine pathway modulation
• Hormone release dynamics

Because these compounds act through separate biological mechanisms, they are frequently studied together to examine how GHRH signalling, ghrelin receptor activation, and growth hormone regulation interact within the endocrine system.

Common Research Applications

CJC-1295 + Ipamorelin is commonly studied in models involving:

• Growth hormone secretion research
• GH pulsatility and release pattern studies
• Endocrine regulation models
• Pituitary function research
• IGF-1 signalling pathways
• Hormonal feedback mechanisms
• Multi-pathway GH axis studies
• Neuroendocrine signalling research

Related Research Peptides

Researchers investigating growth hormone and endocrine signalling pathways may also study:

• CJC-1295 – GHRH analogue research
• Ipamorelin – selective GH secretagogue studies
• GHRP-6 – growth hormone release pathway research
• Sermorelin – GHRH signalling and pituitary studies
• Tesamorelin – growth hormone regulatory pathway research

These compounds are frequently examined within broader studies of endocrine regulation, hormone signalling, and pituitary function.

Product Specifications

• Product Name: CJC-1295 + Ipamorelin
• Compound Type: Dual-Peptide Research Blend
• Contains: CJC-1295 & Ipamorelin
• Research Category: Growth Hormone & Endocrine Research
• Primary Focus Areas: GH Signalling, Pituitary Function & Endocrine Regulation
• Physical Form: Lyophilised (Freeze-Dried) Powder
• Application: Research Use Only

For laboratory research use only – This product is intended solely for research, analytical, and educational purposes. It is not intended for human or animal consumption, therapeutic use, veterinary use, diagnostic procedures, or administration of any kind.